ADMA BIOLOGICS, INC. (ADMA)
Bronstein, Gewirtz & Grossman LLC Urges ADMA Biologics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC Urges ADMA Biologics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
LECTRA: Share buyback program - Aggregated disclosure of transactions in own shares carried out from June 8 to June 12, 2026
Bronstein, Gewirtz & Grossman LLC Urges Via Transportation, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Netflix to Announce Second Quarter 2026 Financial Results
WD-40® Brand Invites DIYers and Pros to Repair, Not Replace in 2026
Wise announces dates for FY2026 results and Q1 FY2027 trading update
Vision Marine Technologies Announces Reverse Stock Split
Incyte maakt op EHA 2026 nieuwe positieve resultaten bekend: INCA033989 leidde tot snelle, krachtige en aanhoudende klinische en moleculaire responsen en werd goed verdragen door patiënten met myelofibrose en essentiële trombocytemie
Incyte annuncia che i nuovi dati positivi presentati allEHA 2026 hanno mostrato che INCA033989 ha ottenuto risposte cliniche e molecolari rapide, solide e sostenute ed è stato ben tollerato in pazienti con mielofibrosi e trombocitemia essenziale
VivaTech 2026: JCDecaux unveils “Le Bus Shelter” and the groundbreaking digital experience “Unlimited DOOH”